FDA announces approval, CMS proposes coverage of first breakthrough-designated test to detect extensive number of cancer biomarkers - FDA Press Releases

FDA/CMS parallel review process makes test for efficient identification of multiple targeted therapy options available to health care professionals, patients and eligible Medicare beneficiaries‎ sooner

from Food and Drug Administration--Press Releases http://ift.tt/2zSIaKc
via IFTTT